Drug repurposing for identification of potential inhibitors against SARS-CoV-2 spike receptor-binding domain: An in silico approach

BACKGROUND & OBJECTIVES: The world is currently under the threat of coronavirus disease 2019 (COVID-19) infection, caused by SARS-CoV-2. The objective of the present investigation was to repurpose the drugs with potential antiviral activity against receptor-binding domain (RBD) of SARS-CoV-2 spi...

Descripción completa

Detalles Bibliográficos
Autores principales: Behera, Santosh Kumar, Mahapatra, Namita, Tripathy, Chandra Sekhar, Pati, Sanghamitra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184087/
https://www.ncbi.nlm.nih.gov/pubmed/33818470
http://dx.doi.org/10.4103/ijmr.IJMR_1132_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184087/
https://www.ncbi.nlm.nih.gov/pubmed/33818470
http://dx.doi.org/10.4103/ijmr.IJMR_1132_20

Ejemplares similares